[Allergic Reactions to Bioimplants]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2022 Mar 28

PMID 35344067

Authors

L Klimek

Affiliations

Soon will be listed here.

Abstract

Background: Bioimplants are used in a variety of ways in otorhinolaryngology, most commonly in facial reconstructive surgery, cochlear implants (CI), bone-anchored hearing aids, and partial/total ossicular replacement prostheses (PORP/TORP), but also for tympanic drainage, laryngeal cannula, voice prostheses after laryngectomy, etc., and in otorhinolaryngology-related procedures as dental implants in dentistry.

Methods: A literature search was performed to analyze the immunology of allergic reactions to bioimplants and to determine the available evidence by searching Medline, PubMed, and national and international study and guideline registries and the Cochrane Library. Human studies published in the period up to and including 12/2021 were considered.

Results: Based on the international literature and previous experience, a review of allergies to bioimplants in otolaryngology is presented.

Conclusion: Otorhinolaryngologists should always consider the possibility of allergic reactions when inserting allogeneic materials, particularly, but not only, when using bioimplants.

References

Klimek L, Bergmann K, Biedermann T, Bousquet J, Hellings P, Jung K . Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of.... Allergo J Int. 2017; 26(1):16-24. PMC: 5288410. DOI: 10.1007/s40629-016-0006-7. View

Ishizaka K, Ishizaka T, HORNBROOK M . Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol. 1966; 97(6):840-53. View

JOHANSSON S . Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet. 1967; 2(7523):951-3. DOI: 10.1016/s0140-6736(67)90792-1. View

Vercelli D . Regulation of IgE synthesis. Allergy Proc. 1993; 14(6):413-6. DOI: 10.2500/108854193778792795. View

Moffatt M, Hill M, Cornelis F, Schou C, Faux J, Young R . Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses. Lancet. 1994; 343(8913):1597-600. DOI: 10.1016/s0140-6736(94)93057-0. View

Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R . Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136(7):2348-57. View

Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni M, Rugiu F . Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol. 1992; 148(7):2142-7. View

Jones H, Inouye J, McGERITY J, Lewis C . Atopic disease and serum immunoglobulin-E. Br J Dermatol. 1975; 92(1):17-25. DOI: 10.1111/j.1365-2133.1975.tb03028.x. View

Kay A, Ying S, Varney V, Gaga M, Durham S, Moqbel R . Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med. 1991; 173(3):775-8. PMC: 2118805. DOI: 10.1084/jem.173.3.775. View

10.

van Reijsen F, Bruijnzeel-Koomen C, Kalthoff F, Maggi E, Romagnani S, Westland J . Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 1992; 90(2):184-93. DOI: 10.1016/0091-6749(92)90070-i. View

11.

Reinhold U, Pawelec G, Wehrmann W, Herold M, Wernet P, Kreysel H . Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol. 1988; 87(2):120-6. DOI: 10.1159/000234661. View

12.

Renz H, Lack G, Saloga J, Schwinzer R, Bradley K, Loader J . Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol. 1994; 152(1):351-60. View

13.

Maurer D, Stingl G . Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J Invest Dermatol. 1995; 104(5):707-10. DOI: 10.1111/1523-1747.ep12606958. View

14.

Gordon J, Flores-Romo L, Cairns J, Millsum M, Lane P, JOHNSON G . CD23: a multi-functional receptor/lymphokine?. Immunol Today. 1989; 10(5):153-7. DOI: 10.1016/0167-5699(89)90171-0. View

15.

DALE H, Laidlaw P . The physiological action of beta-iminazolylethylamine. J Physiol. 1910; 41(5):318-44. PMC: 1512903. DOI: 10.1113/jphysiol.1910.sp001406. View

16.

Samuelsson B . Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983; 220(4597):568-75. DOI: 10.1126/science.6301011. View

17.

Church M, Caulfield J . Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol. 1991; 94(1-4):310-8. DOI: 10.1159/000235393. View

18.

Schleimer R, Sterbinsky S, Kaiser J, Bickel C, Klunk D, Tomioka K . IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol. 1992; 148(4):1086-92. View

19.

Wang J, Rambaldi A, Biondi A, Chen Z, Sanderson C, Mantovani A . Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol. 1989; 19(4):701-5. DOI: 10.1002/eji.1830190420. View

20.

Wardlaw A, Moqbel R, Cromwell O, Kay A . Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest. 1986; 78(6):1701-6. PMC: 423945. DOI: 10.1172/JCI112765. View